We are live on ! Find out more
OPRX icon

OptimizeRx

142 hedge funds and large institutions have $760M invested in OptimizeRx in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 18

114% more call options, than puts

Call options by funds: $55.2M | Put options by funds: $25.8M

34% more capital invested

Capital invested by funds: $567M → $760M (+$192M)

17% more funds holding

Funds holding: 121142 (+21)

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

13% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 40

2.18% more ownership

Funds ownership: 68.96%71.14% (+2.2%)

Holders
142
Holders Change
+21
Holders Change %
+17.36%
% of All Funds
2.47%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.12%
New
39
Increased
45
Reduced
40
Closed
18
Calls
$55.2M
Puts
$25.8M
Net Calls
+$29.4M
Net Calls Change
-$4.32M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$68.3M +$1.29M +25,268 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$47.9M +$4.39M +86,181 +13%
Artisan Partners
3
Artisan Partners
Wisconsin
$47.8M -$23.6K -464 -0.1%
William Blair & Company
4
William Blair & Company
Illinois
$46.7M +$151K +2,971 +0.4%
FLAM
5
First Light Asset Management
Minnesota
$41.2M +$3.59M +70,643 +12%
AC
6
Avenir Corporation
Virginia
$39.5M -$7.63K -150 -0%
Handelsbanken Fonder
7
Handelsbanken Fonder
Sweden
$37.8M +$1.53M +30,000 +5%
AIC
8
AWM Investment Company
New York
$30.3M -$515K -10,124 -2%
GIPM
9
G2 Investment Partners Management
New York
$25.1M -$3.02M -59,291 -13%
JAMONY
10
Jacob Asset Management of New York
California
$20.9M +$1.02M +20,000 +6%
NCGI
11
Next Century Growth Investors
Minnesota
$20M -$2.11M -41,371 -11%
PCA
12
Prospect Capital Advisors
California
$19M +$15.6M +307,150 New
State Street
13
State Street
Massachusetts
$18.9M +$1.63M +31,941 +12%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$17.8M +$912K +17,913 +7%
BAM
15
Bullseye Asset Management
Colorado
$13.8M
VCM
16
Venator Capital Management
Ontario, Canada
$13.5M +$585K +11,500 +6%
PCM
17
Peregrine Capital Management
Minnesota
$12.5M -$1.71M -33,684 -14%
WA
18
Wasatch Advisors
Utah
$11.4M
Northern Trust
19
Northern Trust
Illinois
$11.3M -$1.47M -28,802 -14%
Two Sigma Investments
20
Two Sigma Investments
New York
$10.6M -$3.84M -75,492 -31%
Federated Hermes
21
Federated Hermes
Pennsylvania
$10.2M +$2M +39,263 +31%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$10.1M -$468K -9,200 -5%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$9.64M +$2.62M +51,396 +49%
CM
24
Castleark Management
Illinois
$9.53M +$3.31M +65,077 +73%
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$8.63M +$93.3K +1,834 +1%

OPRX Hedge Fund Activity: Q2 2021 in Review

142 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q2 2021, worth a combined $760M — up 34% from $567M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new OPRX positions and 18 closed out — a net gain of 21 holders — while 45 added to existing stakes and 40 trimmed.

The largest buyer was Prospect Capital Advisors, opening a new position worth an estimated $15.6M. The largest seller was Maven Securities, cutting an estimated $5.73M.

  • 142 institutional investors held OptimizeRx (OPRX) as of Q2 2021, up from 121 in Q1 2021.
  • Funds reported $760M of OptimizeRx stock for Q2 2021, up 34% quarter-over-quarter.
  • 39 funds opened new OptimizeRx positions in Q2 2021 and 18 closed out, a net change of +21 holders.
  • The largest OptimizeRx buyer in Q2 2021 was Prospect Capital Advisors, an estimated $15.6M added.
  • The largest OptimizeRx seller in Q2 2021 was Maven Securities, an estimated $5.73M sold.

Based on aggregated 13F filings for Q2 2021.